9 / 386
03
SELECTED
FINANCIAL INFORMATION
SUMMARY OF KEY DATA
Pursuant to IFRS 5, the data reported for revenue, operating income, EBITDA, operating cash flow and net debt concern the continuing operations exclusively, i.e. mainly
the OL3 project, bioenergy operations in the process of being discontinued, and AREVA SA funding.
(in millions of euros, except workforce)
2016
2015
Change
2016/2015
Income
Reported revenue
10
33
-23
Gross margin
(408)
(917)
+509
Operating income
(442)
(1,287)
+845
Net financial income
(68)
(46)
-22
Share in net income of joint ventures and associates
(14)
(26)
+12
Net income from discontinued operations
(365)
(770)
+405
Consolidated net income
(665)
(2,038)
+1,373
Comprehensive income
(809)
(1,905)
+1,096
Comprehensive income attributable to equity owners of the parent
(753)
(1,825)
+1,072
Cash flow
EBITDA
(684)
(630)
-54
Change in operating working capital requirement
95
166
-71
Net operating Capex
(7)
(12)
+5
Operating cash flow
(590)
(475)
-115
Miscellaneous
Net cash (debt)
(1,473)
(6,323)
+4,850
Equity attributable to owners of the parent
(3,417)
(2,516)
-901
Workforce (end of period, including operations held for sale)
36,241
39,761
-8.9%
Dividend per share
-
-
-
2016 AREVA
REFERENCE DOCUMENT
9